Drug General Information (ID: DDIX0DH1AN)
  Drug Name Ketorolac (ophthalmic) Drug Info Acetylcholine Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Analgesics Cardiovascular Agents
  Structure

 Mechanism of Ketorolac (ophthalmic)-Acetylcholine Interaction (Severity Level: Minor)
     Antagonize the effect of cholinergic agents Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Ketorolac (ophthalmic) Acetylcholine
      Mechanism Antagonize the miotic activity of acetylcholine Acetylcholine
      Key Mechanism Factor 1
Factor Name Cholinergic agents
Factor Description The beneficial effects of cholinergic drugs may be reduced, such as reduced efficacy in the treatment of Alzheimer's disease and exacerbation of symptoms in the treatment of myasthenia gravis.
      Mechanism Description
  • Antagonize the effect of Ketorolac (ophthalmic) when combined with Acetylcholine 

References
1 Product Information. Nevanac (nepafenac ophthalmic). Alcon Laboratories Inc, Fort Worth, TX.
2 Holmes JM, Jay WM "The effect of preoperative flurbiprofen on miosis produced by acetylcholine during cataract surgery." Am J Ophthalmol 111 (1991): 735-8